Estimates

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-21.

Street snapshot

The mean price target is ₹517 (median ₹516), spanning a low of ₹425 to a high of ₹610.

Currency: INR · Scale: money in millions, absolute (per share) · Analyst counts shown explicitly; recommendation respondents: 12.

Street view Reading Analysts
Recommendation mix Buy 11, Outperform 1, Hold 0, Underperform 0, Sell 0 12
Consensus score 1.08 12
Target price mean 516.8; high 610.0; low 425.0 12

Forward table

Consensus models steady growth, with revenue rising from ₹12,098 in FY2026 to ₹14,954 (FY2027) and ₹17,621 (FY2028), and normalized EPS advancing from 16.31 to 18.98 to 22.49. Gross margin is held near 49% across the horizon.

Currency: INR · Scale: money in millions, absolute (per share) · Analyst count is the estimate count for each period and metric.

Period Metric Mean YoY Analysts Low / high
FY0E Revenue 14,954 33.1% 11 13,190 / 18,586
FY0E EBITDA 3,704 21.5% 8 3,485 / 3,973
FY0E EBIT 3,580 18.7% — / —
FY0E Net income (GAAP) 2,846 39.3% 10 2,490 / 3,693
FY0E Net income (normalized) 2,846 25.7% — / —
FY0E EPS (GAAP) 18.93 35.8% 11 16.57 / 25.20
FY0E EPS (normalized) 18.98 36.2% 11 16.60 / 25.20
FY0E Free cash flow 5,084 72.0% — / —
FY0E Dividend per share 1.50 -3.6% — / —
FY0E Gross margin 49.4% 1.4% — / —
FY0E Capital expenditure -305.3 37.1% — / —
FY0E Net debt 1,224 -60.9% — / —
FY0E ROE 7.7% 20.8% — / —
FY0E Cash from operations 3,544 80.7% — / —
FY+1E Revenue 17,621 17.8% 11 14,758 / 21,223
FY+1E EBITDA 4,768 28.7% 12 3,267 / 6,994
FY+1E EBIT 4,576 27.8% — / —
FY+1E Net income (GAAP) 3,317 16.6% 12 2,460 / 4,650
FY+1E Net income (normalized) 3,321 16.7% — / —
FY+1E EPS (GAAP) 22.45 18.6% 12 16.80 / 33.00
FY+1E EPS (normalized) 22.49 18.5% 12 16.80 / 33.45
FY+1E Free cash flow -156.5 -103.1% — / —
FY+1E Dividend per share 1.50 0.3% — / —
FY+1E Gross margin 49.5% 0.3% — / —
FY+1E Capital expenditure -432.2 41.6% — / —
FY+1E Net debt 1,834 49.9% — / —
FY+1E Cash from operations 2,931 -17.3% — / —
FY+1E ROE 8.1% 5.0% — / —
FY+2E Revenue 25,197 43.0% 5 19,448 / 35,745
FY+2E EBITDA 7,164 50.3% 5 3,268 / 11,553
FY+2E EBIT 6,819 49.0% — / —
FY+2E Net income (GAAP) 5,056 52.4% 5 2,550 / 7,915
FY+2E Net income (normalized) 5,056 52.3% — / —
FY+2E EPS (GAAP) 34.62 54.2% 5 16.10 / 56.00
FY+2E EPS (normalized) 34.62 54.0% 5 16.10 / 56.00
FY+2E Free cash flow 1,406 -998.4% — / —
FY+2E Dividend per share 3.05 102.7% — / —
FY+2E Gross margin 48.8% -1.6% — / —
FY+2E Capital expenditure -1,365 215.7% — / —
FY+2E Net debt 121.0 -93.4% — / —
FY+2E Cash from operations 2,357 -19.6% — / —
FY+2E ROE 11.1% 37.8% — / —
Q2 FY2027 Revenue 3,296 30.6% 1 3,296 / 3,296
Q2 FY2027 EBITDA 861.0 10.6% 1 861.0 / 861.0
Q2 FY2027 EBIT 820.0 17.8% — / —
Q2 FY2027 Net income (GAAP) 562.0 14.8% 1 562.0 / 562.0
Q2 FY2027 Net income (normalized) 562.0 10.6% — / —
Q2 FY2027 EPS (GAAP) 3.80 13.8% 1 3.80 / 3.80
Q2 FY2027 EPS (normalized) 3.80 13.8% 1 3.80 / 3.80
Q2 FY2027 Gross margin 50.5% — / —
Q3 FY2027 Revenue 3,726 8.3% 1 3,726 / 3,726
Q3 FY2027 EBITDA 1,048 28.6% 1 1,048 / 1,048
Q3 FY2027 EBIT 1,005 12.8% — / —
Q3 FY2027 Net income (GAAP) 708.0 21.6% 1 708.0 / 708.0
Q3 FY2027 Net income (normalized) 708.0 22.8% — / —
Q3 FY2027 EPS (GAAP) 4.80 20.9% 1 4.80 / 4.80
Q3 FY2027 EPS (normalized) 4.80 20.9% 1 4.80 / 4.80
Q3 FY2027 Gross margin 50.5% 8.1% — / —
Q4 FY2027 Revenue 4,442 31.0% 1 4,442 / 4,442
Q4 FY2027 EBITDA 1,372 41.9% 1 1,372 / 1,372
Q4 FY2027 EBIT 1,328 30.9% — / —
Q4 FY2027 Net income (GAAP) 949.0 48.9% 1 949.0 / 949.0
Q4 FY2027 Net income (normalized) 949.0 35.1% — / —
Q4 FY2027 EPS (GAAP) 6.50 49.8% 1 6.50 / 6.50
Q4 FY2027 EPS (normalized) 6.50 49.8% 1 6.50 / 6.50
Q4 FY2027 Gross margin 50.5% 15.0% — / —

Estimate momentum

Recent revisions lean lower on both metrics and both years: FY2027 normalized EPS has slipped from 20.77 (180 days ago) to 18.98, and FY2027 revenue from 17,955 (90 days ago) to 14,954. FY2028 moves the same way, with normalized EPS easing from 25.84 to 22.49.

Currency: INR · Scale: money in millions, absolute (per share) · Point-in-time consensus; analyst count is shown where supplied.

Period Metric Lookback Then Now Direction / magnitude Analysts
2027 EPS (normalized) 30d 18.98 18.98 flat 0.0%
2027 EPS (normalized) 90d 26.60 18.98 down 28.6%
2027 EPS (normalized) 180d 20.77 18.98 down 8.6%
2027 Revenue 30d 14,954 14,954 flat 0.0%
2027 Revenue 90d 17,955 14,954 down 16.7%
2027 Revenue 180d 15,880 14,954 down 5.8%
2028 Revenue 30d 17,621 17,621 flat 0.0%
2028 Revenue 90d 19,220 17,621 down 8.3%
2028 Revenue 180d 19,319 17,621 down 8.8%
2028 EPS (normalized) 30d 22.49 22.49 flat 0.0%
2028 EPS (normalized) 90d 26.76 22.49 down 16.0%
2028 EPS (normalized) 180d 25.84 22.49 down 13.0%

Beat / miss record

Current sequences by metric: Revenue: 2 consecutive misses; EPS (normalized): 1 consecutive beat.

Currency: INR · Scale: money in millions, absolute (per share) · Consensus is captured before each actual first became effective; analyst count shown per observation.

Quarter Metric Consensus as of Actual Surprise Outcome Analysts
Q1 FY2027 Revenue 2,788 1,916 -31.3% Miss
Q1 FY2027 EPS (normalized) 2.80 2.88 2.9% Beat
Q4 FY2026 Revenue 4,059 3,390 -16.5% Miss
Q4 FY2026 EPS (normalized) 5.40 4.34 -19.6% Miss
Q3 FY2026 Revenue 2,981 3,441 15.4% Beat
Q3 FY2026 EPS (normalized) 4.15 3.97 -4.3% Miss
Q2 FY2026 Revenue 2,517 2,524 0.3% Beat
Q2 FY2026 EPS (normalized) 3.75 3.34 -10.9% Miss
Q1 FY2026 Revenue 2,860 1,883 -34.2% Miss
Q4 FY2025 Revenue 4,551 2,060 -54.7% Miss
Q4 FY2025 EPS (normalized) 5.30 3.44 -35.1% Miss
Q3 FY2025 Revenue 1,972 1,618 -18.0% Miss
Q2 FY2025 Revenue 3,141 1,690 -46.2% Miss
Q2 FY2025 EPS (normalized) 3.20 2.36 -26.2% Miss

Where the street disagrees

Disagreement widens sharply in the outer years, where coverage thins: FY2029 revenue spans ₹19,448 to ₹35,745 on just 5 estimates, and FY2029 normalized EPS ranges 16.1 to 56.

Currency: INR · Scale: money in millions, absolute (per share) · Dispersion is high-low divided by absolute mean; analyst count shown per item.

Period Metric Mean Low High Spread / mean Analysts
2029 EBITDA 7,164 3,268 11,553 115.6% 5
2029 EPS (GAAP) 34.62 16.10 56.00 115.3% 5
2029 EPS (normalized) 34.62 16.10 56.00 115.3% 5
2029 Net income (GAAP) 5,056 2,550 7,915 106.1% 5
Q3 FY2025 Revenue 1,972 942.0 3,002 104.5% 2